3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one manufacturers
- Sevabertinib
-
-
2026-09-11
- CAS:2521285-05-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10 KG
|
| | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one Basic information |
| Product Name: | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | | Synonyms: | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one;3-(3-chloro-2-methoxy-anilino)-2-[3-[[(2S)-1,4-dioxan-2-yl]methoxy]-4-pyridyl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one;(S)-2-[3-[(1,4-Dioxan-2-yl)methoxy]-4-pyridyl]-3-[(3-chloro-2-methoxyphenyl)amino]-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one;(S)-2-(3-((1,4-Dioxan-2-yl)methoxy)pyridin-4-yl)-3-((3-chloro-2-methoxyphenyl)amino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one;Dual EGFR-HER2 inhibitor Sevabertinib (BAY 2927088);Sevabertinib BAY 2927088 | | CAS: | 2521285-05-0 | | MF: | C24H25ClN4O5 | | MW: | 484.93 | | EINECS: | | | Product Categories: | API | | Mol File: | 2521285-05-0.mol | ![3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one Structure](CAS/20210305/GIF/2521285-05-0.gif) |
| | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one Chemical Properties |
| Boiling point | 730.8±60.0 °C(Predicted) | | density | 1.361±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 13.38±0.20(Predicted) | | InChIKey | VYQVHWNNPKOJEA-AWEZNQCLSA-N | | SMILES | C1(=O)NCCC2NC(C3C=CN=CC=3OC[C@@H]3COCCO3)=C(NC3=CC=CC(Cl)=C3OC)C1=2 |
| | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one Usage And Synthesis |
| Uses | Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |
| | 3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one Preparation Products And Raw materials |
|